501 related articles for article (PubMed ID: 2428860)
1. Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.
Romaldini JH; Werner MC; Rodrigues HF; Teixeira VL; Werner RS; Farah CS; Bromberg N
J Endocrinol Invest; 1986 Jun; 9(3):233-8. PubMed ID: 2428860
[TBL] [Abstract][Full Text] [Related]
2. [Thyroid hormone autoantibodies in Hashimoto's disease and Graves' disease].
Nakamura S; Murayama M; Kojima N; Kamikubo K; Sakata S; Yasuda K; Miura K
Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1597-607. PubMed ID: 6689304
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
4. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
5. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
7. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.
Wenzel KW; Lente JR
J Clin Endocrinol Metab; 1984 Jan; 58(1):62-9. PubMed ID: 6196375
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.
Homsanit M; Sriussadaporn S; Vannasaeng S; Peerapatdit T; Nitiyanant W; Vichayanrat A
Clin Endocrinol (Oxf); 2001 Mar; 54(3):385-90. PubMed ID: 11298092
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
Inukai T; Takanashi K; Takebayashi K; Fujiwara Y; Tayama K; Takemura Y
Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
[TBL] [Abstract][Full Text] [Related]
10. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
11. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
[TBL] [Abstract][Full Text] [Related]
12. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
Choo YK; Yoo WS; Kim DW; Chung HK
Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis.
Wenzel BE; Chow A; Baur R; Schleusener H; Wall JR
Thyroid; 1998 Nov; 8(11):1019-22. PubMed ID: 9848716
[TBL] [Abstract][Full Text] [Related]
14. Three patients who spontaneously developed persistent hypothyroidism during or following treatment with antithyroid drugs for Graves' hyperthyroidism.
Shigemasa C; Mitani Y; Taniguchi S; Adachi T; Ueta Y; Urabe K; Miyazaki S; Tanaka T; Yoshida A; Mashiba H
Arch Intern Med; 1990 May; 150(5):1105-9. PubMed ID: 1691909
[TBL] [Abstract][Full Text] [Related]
15. Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves' disease.
Tada H; Mizuta I; Takano T; Tatsumi KI; Izumi Y; Hidaka Y; Amino N
Clin Endocrinol (Oxf); 2003 Apr; 58(4):403-8. PubMed ID: 12641621
[TBL] [Abstract][Full Text] [Related]
16. Thyroid T4 5'-deiodinase activity in normal and abnormal human thyroid glands.
Sugawara M; Lau R; Wasser HL; Nelson AM; Kuma K; Hershman JM
Metabolism; 1984 Apr; 33(4):332-6. PubMed ID: 6200749
[TBL] [Abstract][Full Text] [Related]
17. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
[TBL] [Abstract][Full Text] [Related]
18. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
Okamoto Y; Hamada N; Saito H; Ohno M; Noh J; Ito K; Morii H
J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
[TBL] [Abstract][Full Text] [Related]
19. Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients.
Ohashi H; Okugawa T; Itoh M
Acta Endocrinol (Copenh); 1991 Nov; 125(5):502-9. PubMed ID: 1684685
[TBL] [Abstract][Full Text] [Related]
20. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
